ripekg:evaluation/RIPEAD0800A4DFB9CD804 |
prov:used |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAD0800A4DFB9CD804 |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAD0800A4DFB9CD804 |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
ripe:concerns |
ripekg:work/10.1007%2Fs13318-014-0242-5The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
ripe:recruitmentEndDateExtractionRationale |
No recruitment finish date found. |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
ripe:recruitmentStartDateExtractionRationale |
No recruitment start date found. |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
ripe:studyEndDateExtractionRationale |
No study end date found. |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAD0800A4DFB9CD804-human-2-2 |
ripekg:study-design-evidence/RIPEAD0800A4DFB9CD804 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAD0800A4DFB9CD804-inspectai-2-2 |